Posts by: Chris Commish

Chris Commish

Chris Comish is the Publisher of Cystic Fibrosis News Today.

May 6, 2014May 8, 2014

Trial For Cystic Fibrosis Drug AZLI To Treat Chronic Burkholderia Species Infection Completed

News

There is some good news for cystic fibrosis patients who suffer with Chronic Burkholderia Species Infection. A Phase 3b clinical trial for Aztreonam, a therapeutic for use in CF patients with ... Read more

May 5, 2014July 4, 2016

Xenetic Biosciences CF Drug PulmoXen Found To Be Safe, Effective In Cystic Fibrosis Patients

News

Xenetic Biosciences recently announced that the drug developer’s Phase I clinical trial of its new cystic fibrosis treatment PulmoXen has yielded positive results in the treatment of the disease. The announcement ... Read more

May 2, 2014May 8, 2014

Promising Cystic Fibrosis Therapy ARIKACE From Insmed To Treat Pseudomonas Aeruginosa Reported as Well-Tolerated In Two-Year, Open-Label Extension Study

News

While Cystic Fibrosis news is never in short supply, often times, many clinical trials currently underway to test experimental CF therapies are underreported by the media, who instead seek to ... Read more

April 28, 2014May 8, 2014

Opko Seeks to Pair Cystic Fibrosis, Respiratory Drugs With Digital Inhaler Device

News

According to a recent press release, the respiratory drug developer Opko Health has acquired Inspiro Media Ltd., which has developed a “smart,” easy-to-use powder digital inhaler to deliver small molecule ... Read more